Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF)

Pharmacological Reports

Volumn 61, Issue 6, 2009, Pages 1017-1023

  Czubak, Anna ^a   Nowakowska, Elzbieta ^a   Kus, Krzysztof ^a   Burda, Kinga ^a   Metelska, Jana ^a   Baer Dubowska, Wanda ^a   Cichocki, Michał ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Brain derived neurotrophic factor; Nicotine; Olanzapine; Rat brain; Venlafaxine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NICOTINE; OLANZAPINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESPONSE; HIPPOCAMPUS; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SYNAPSE;

EID: 76049121016     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70163-X     Document Type: Article

References (64)

1. Aghajanian GK, Marek GJ: Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev, 2000, 31, 302-312.
2. Aloe L, Iannitelli A, Angelucci F, Bersani G, Fiore M: Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders. Behav Pharmacol, 2000, 11, 235-242.
3. Altar C, DiStefano PS: Neurotrophin trafficking by anterograde transport. Trends Neurosci, 1998, 21, 433-437.
4. Angelucci F, Mathé AA, Aloe L: Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res, 2004, 146, 151-165.
5. Bai O, Chlan-Fourney J, Bowen R, Keggan D, Li XM.: Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res, 2003, 71, 127-131.
6. Berninger B, Marty S, Zafra F, da Penha Berzaghi M, Thoenen H, Lindholm D: GABAergic stimulation switches from enhancing to repressing BDNF expression in rat hippocampal neurons during maturation in vitro. Development, 1995, 121, 2327-2335.
7. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA: Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology, 2007, 32, 2351-2359.
8. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry, 2001, 50, 260-265.
9. Coppell AL, Pei Q, Zetterström TSC: Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology, 2003, 44, 903-910.
10. Czubak A, Nowakowska E, Kus K, Matschay A, Kokot Z: The effects of nicotine and mecamylamine on spatial memory in rats. Eur Neuropsychopharmacol, 2007, 17, 253-254.
11. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry, 1997, 54, 597-605.
12. Duman RS, Malberg J, Nakagawa S, D' Sa C: Neuronal plasticity and survival in mood disorders. Biol Psychiatry, 2000, 48, 732-739.
13. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry, 2006, 59, 1116-1127.
14. Fiore M, Korf J, Angelucci F, Talamini L, Aloe L: Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases. Physiol Behav, 2000, 71, 57-67.
15. Freedman R,Wetmore C, Stromberg I, Leonard S, Olson L: α-Bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci, 1993, 13, 1965-1975.
16. Ghosh A, Carnahan J, Greenberg ME: Requirement for BDNF in activity-dependent survival of cortical neurons. Science, 1994, 263, 1618-1623.
17. Hall J, Thomas KL, Everitt BJ: Rapid and selective induction in BDNF expression in the hippocampus during contextual learning. Nature Neurosci, 2000, 3, 533-535.
18. Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC: Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog Neuro-Psychopharmacol Biol Psychiatry, 2003, 27, 801-807.
19. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res, 2002, 109, 143-148.
20. Kenny PJ, File SE, Rattray M: Acute nicotine decreases, and chronic nicotine increases the expression of brainderived neurotrophic factor mRNA in rat hippocampus. Mol Brain Res, 2000, 85, 234-238.
21. Kesslak JP, So V, Choi J, Cotman CW, Gomez-Pinilla F: Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav Neurosci, 1998, 112, 1012-1019.
22. Knipper M, Da Penha Berzaghi M, Blochl A, Thoenen H, Lindholm D: Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brainderived neurotrophic factor in the rat hippocampus. Eur J Neurosci, 1994, 6, 668-671.
23. Koponen E, Rantamaki T, Voikar V, Saarelainen T, Mac-Donald E, Castrén E: Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol, 2005, 25, 973-979.
24. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T: Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor, Proc Natl Acad Sci USA, 1995, 92, 8856-8860.
25. Lapchak PA, Araujo DM, Hefti F: Cholinergic regulation of hippocampal brain-derived neurotrophic factor mRNA expression: evidence from lesion and chronic cholinergic drug treatment studies. Neuroscience, 1993, 52, 575-85.
26. Lipska BK, Khaing ZZ, Weickert CS, Weinberger DR: BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur J Neurosci, 2001, 14, 135-144.
27. Lo DC: Neurotrophic factors and synaptic plasticity. Neuron, 1995, 15, 979-981.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem, 1951, 193, 265-275.
29. Lu B: BDNF and activity-dependent synaptic modulation. Learn Mem, 2003, 10, 86-98.
30. Mannari C, Origlia N, Scatena A, Del Debbio A, Catena M, Dell'Agnello G, Barraco A et al.: BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake Cell Mol Neurobiol, 2008, 28, 457-468.
31. McAllister AK, Katz LC, Lo DC: Neurotrophins and synaptic plasticity. Ann Rev Neurosci, 1999, 22, 295-318.
32. Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T: Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci, 2000, 20, 2122-2130.
33. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci, 1995, 15, 7539-7547.
34. Nibuya M, Nestler EJ, Duman RS: Chronic antidepressant administration increases the expression of cAMP re-sponse element binding protein (CREB) in rat hippocampus. J Neurosci, 1996, 16, 2365-2372.
35. Nowakowska E, Chodera A, Kus K: Influence of olanzapine on cognitive functions and catalepsy in rats after single and chronic administration. Pol J Pharmacol, 1999, 51, 295-300.
36. Nowakowska E, Kus K: Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats. Arzneimittelforschung, 2005, 55, 153-159.
37. Nowakowska E, Kus K, Bobkiewicz-Kozłowska T, Hertmanowska H: Role of neuropeptides in antidepressant and memory improving effects of venlafaxine. Pol J Pharmacol, 2002, 54, 605-613.
38. Nowakowska E, Kus K, Czubak A: Antidepressant effects of venlafaxine and nicotine in rats - behavioral and receptor studies. Pharmacol Rep, 2008, 60, 269-270.
39. Nowakowska E, Kus K, Florek E, Czubak A, Jodynis-Liebert J, Hertmanowska H: The influence of tobacco smoke and nicotine on antidepressant and memory improving effects of venlafaxine. Hum Exp Toxicol, 2006, 25, 199-209.
40. Pang PT, Teng HK, Woo ZE, Sakata NT, Zhen K, Teng S, Yung KK et al.: Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science, 2004, 306, 487-491.
41. Parikh V, Khan MM, Mahadik SP: Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neurosci Lett, 2004, 356, 135-139.
42. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel EC: Recombinant BDNF rescues deficits in basal synaptic transmission in hippocampal LTP in BDNF knockout mice. Neuron, 1996, 16, 1137-1145.
43. Pillai A, Terry AV, Mahadik SP: Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res, 2006, 82, 95-106
44. Poo MM: Neurotrophins as synaptic modulators. Nat Rev Neurosci, 2001, 2, 24-32.
45. Ridley DL, Balfour DJK: The influence of nicotine on 5-HT overflow in the dorsal hippocampus of the rat. Br J Pharmacol, 1997, 122, 192.
46. Rizos EN, Papadopoulou A, Laskos E, Michalopoulou PG, Kastania A, Vasilopoulos D, Katsafouros K et al.: Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry, 2008, 10, 1-5.
47. Rogóż Z, Legutko B: Combined treatment with imipramine and metyrapone induces hippocampal and cortical brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep, 2005, 57, 840-844.
48. Rogóż Z, Skuza G, Legutko B: Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep, 2008, 60, 817-826.
49. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW: Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience, 2000, 101, 305-312.
50. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry, 2003, 54, 70-75.
51. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS: Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. J Neurosci, 2002, 22, 3251-3261.
52. Shoaib M, Schindler CW, Goldberg SG, Pauly JR: Behavioural and biochemical adaptations to nicotine in rats: influence of MK-801, an NMDA receptor antagonist. Psychopharmacology, 1997, 134, 121-130.
53. Shoval G, Weizman A: The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol, 2005, 15, 319-29.
54. Siuciak JA, Lewis DR, Weigand SJ, Lindsay R: Antidepressant-like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Behav, 1997, 56, 131-137.
55. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi S: Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry, 2000, 5, 293-300.
56. Thoenen H: Neurotrophins and neuronal plasticity. Science, 1995, 270, 593-598.
57. Thome J, Foley P, Riederer P: Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article. J Neural Transm, 1998, 105, 85-100.
58. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD: From acquisition to consolidation: on the role of brainderived neurotrophic factor signaling in hippocampaldependent learning. Learn Mem, 2002, 9, 224-237.
59. 2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci, 1997, 17, 2785-2795.
60. Vaidya VA, Siuciak JA, Du F, Duman RS: Hippocampal mossy fibre sprouting induced by chronic electroconvulsive seizures. Neuroscience, 1999, 89, 157-166.
61. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE: Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry, 2003, 8, 592-610.
62. Xu B, Zang K, Ruff NL, Zhang YA, McConnell SK, Stryker MP, Reichardt LF: Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron, 2000, 26, 233-245.
63. Xu H, Richardson JS, Li XM: Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology, 2003, 28, 53-62.
64. Yamada K, Mizuno M, Nabeshima T: Role for brainderived neurotrophic factor in learning and memory. Life Sci, 2002, 70, 735-744.